Jounce Therapeutics (JNCE)
NASDAQ:JNCE
Holding JNCE?
Track your performance easily

Jounce Therapeutics (JNCE) Cash flow

0 Followers

Jounce Therapeutics Cash Flow

JNCE's free cash flow for Q was $59.01M. For the fiscal year, JNCE's free cash flow was decreased by $54.07M and operating cash flow was $59.23M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -28.88M$ -28.88M$ -83.49M$ -27.79M$ -30.13M$ -63.61M
Investing Cash Flow
$ 83.48M$ 83.48M$ -60.51M$ 51.30M$ 31.38M$ 86.41M
Financing Cash Flow
$ 442.00K$ 442.00K$ 92.04M$ 70.74M$ 4.08M$ 1.55M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 370.92M$ 151.84M$ 96.80M$ 148.76M$ 54.51M$ 49.18M
Income Tax Paid Supplemental Data
$ 17.00K$ 17.00K$ 8.00K$ 45.00K$ 101.00K$ 0.00
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--$ 90.83M$ 70.14M$ 3.65M$ 0.00
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -29.80M$ -29.80M$ -83.87M$ -27.88M$ -31.11M$ -64.97M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Jounce Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis